Geftistar 250mg Tablet
Marketer
Lupin Ltd
Salt Composition
Gefitinib (250mg)
Overview Geftistar 250mg Tablet
Afatinib 250mg tablets treat advanced non-small cell lung cancer that has metastasized, affecting individuals with abnormal epidermal growth factor receptor (EGFR) genes and without prior cancer therapy. Dosage is as prescribed; continue treatment as directed by your physician, duration varying based on individual response. Regular liver function checks may be recommended. Common adverse effects include nausea, diarrhea, dry skin, and appetite loss; increased fluid intake may mitigate these. Report any concerning or worsening side effects. Immediately report mouth sores, vision changes, or respiratory distress. Women should employ reliable contraception throughout treatment and for one month post-treatment to prevent pregnancy. Disclose all other medications to your doctor.
Uses of Geftistar 250mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Geftistar 250mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 250mg Geftistar tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Geftistar 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geftistar 250mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the 250mg Geftistar tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
How Geftistar 250mg Tablet works:
Xeljanz 250mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for cancer cell proliferation, thus curbing or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Geftistar 250mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Geftistar 250mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical, life-threatening cases where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Geftistar 250mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Geftistar 250mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Geftistar 250mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver conditions may generally tolerate Geftistar 250mg Tablets. Available evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Geftistar 250mg Tablet :
Omit any missed Geftistar 250mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Geftistar 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently
